CARDIORA
Cardiora is a clinical stage biopharmaceutical company that was established in 2015. Cardiora is focussed on developing new treatments for patients with end stage heart failure, which is associated with high mortality rates, recurrent hospital admissions and poor quality of life. Cardiora’s lead program is currently in Phase Ib trials, and IND enabling trials are currently being completed. Cardiora intends to enter Phase II trials in 2017.
CARDIORA
Industry:
Biopharma Health Care Wellness
Founded:
2015-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.cardiora.com
Total Employee:
11+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Alsonex
Alsonex is a biopharmaceutical company focused on the development of new treatments for neurodegenerative disease.
Trutino Biosciences
Trutino Biosciences is a iopharmaceutical company that develops the next generation cytokine therapies.
Investors List
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Seed Round - Cardiora
Brandon Capital Partners
Brandon Capital Partners investment in Seed Round - Cardiora
